India holds almost 16% of the world population with a large and diverse patient pool in almost every therapeutic
area with most of the populations tolerant to pharmacogenomic sampling. India also has different regions with
conserved population gene pools. This gives India an added advantage in clinical research apart from the direct
economic benefits.
We have developed our investigator network on the guidelines of the NIH-Roadmap of Medical Research for a better
translation of scientific discovery into clinical practice. We see clinical research as a vital sector of
translational medicine and a bottle neck of drug discovery which needs the re-engineering measures for an efficient
outcome. Our inventory of network investigators belong to a whole spectrum of therapeutic areas which have the
capability of investigating the blockbuster drugs as well as the nichebuster drugs developed as personalized
therapies in the evolving theragnostic model.
Our Therapeutic Domains
- Endocrinology
- Cardiovascular
- Women’s Health
- Oncology
- Rheumatology
- Respiratory disorders
- Central Nervous System disorders
- Gastroenterology
- Pain Management
- Dermatology
- Infectious diseases
- Paediatrics
- Ophthalmology
|
